VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma

Molecular and Cellular Biochemistry

Volumn 400, Issue 1-2, 2015, Pages 87-95

  Zhao, Dong ^a   Jia, Peng ^a   Wang, Wenliang ^a   Zhang, Guangling ^b  

^a Logistics University of PAP(People s Armed Police)   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

Invasion; miR 410; Osteosarcoma; Proliferation; VEGF

Indexed keywords

DNA; MESSENGER RNA; MICRORNA; MICRORNA 125A; MICRORNA 29A; MICRORNA 410; MICRORNA 579; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN; MIRN410 MICRORNA, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; MTS ASSAY; MTT ASSAY; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; BONE TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84922074808     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2265-2     Document Type: Article

References (24)

1. Tan JZ, Schlicht SM, Powell GJ, Thomas D, Slavin JL, Smith PJ, Choong PF (2006) Multidisciplinary approach to diagnosis and management of osteosarcoma—a review of the St Vincent’s Hospital experience. Int semin surg oncol 3:38. doi:10.1186/1477-7800-3-38
2. Akiyama T, Dass CR, Choong PF (2008) Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway. Mol Cancer Ther 7(11):3461–3469. doi:10.1158/1535-7163.MCT-08-0530
3. Ferrari S, Palmerini E (2007) Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol 19(4):341–346. doi:10.1097/CCO.0b013e328122d73f
4. van Rooij E (2011) The art of microRNA research. Circ Res 108(2):219–234. doi:10.1161/CIRCRESAHA.110.227496
5. Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A (2010) MicroRNAs, macrocontrol: regulation of miRNA processing. RNA 16(6):1087–1095. doi:10.1261/rna.1804410
6. Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE, Abdellatif M, Feldman DS, Elton TS, Gyorke S (2009) miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res 104(4):514–521. doi:10.1161/CIRCRESAHA.108.181651
7. Maraghechi P, Hiripi L, Toth G, Bontovics B, Bosze Z, Gocza E (2013) Discovery of pluripotency-associated microRNAs in rabbit preimplantation embryos and embryonic stem-like cells. Reproduction 145(4):421–437. doi:10.1530/REP-12-0259
8. Yang H, Kong W, He L, Zhao JJ, O’Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68(2):425–433. doi:10.1158/0008-5472.CAN-07-2488
9. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21):9628–9632. doi:10.1158/0008-5472.CAN-05-2352
10. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283(2):1026–1033. doi:10.1074/jbc.M707224200
11. Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137(6):2136–2145. doi:10.1053/j.gastro.2009.08.065 e2131–2137
12. Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G, Comoglio PM, Columbano A, Giordano S (2012) MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin cancer res 18(3):737–747. doi:10.1158/1078-0432.CCR-11-1699
13. Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, Lai L, Jiang BH (2012) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40(2):761–774. doi:10.1093/nar/gkr730
14. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17(2):211–215. doi:10.1038/nm.2284
15. Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES (2012) miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 72(4):908–916. doi:10.1158/0008-5472.CAN-11-1460
16. Zhao H, Ma B, Wang Y, Han T, Zheng L, Sun C, Liu T, Zhang Y, Qiu X, Fan Q (2013) miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncol Rep 29(3):1027–1036. doi:10.3892/or.2013.2234
17. Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma YL, Ji ZW, Li XX, Han K, Gao J, Qiu XC, Fan QY, Yang TT, Ma BA (2012) miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep 28(5):1764–1770. doi:10.3892/or.2012.1995
18. He C, Xiong J, Xu X, Lu W, Liu L, Xiao D, Wang D (2009) Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun 388(1):35–40. doi:10.1016/j.bbrc.2009.07.101
19. Chen L, Zhang J, Feng Y, Li R, Sun X, Du W, Piao X, Wang H, Yang D, Sun Y, Li X, Jiang T, Kang C, Li Y, Jiang C (2012) MiR-410 regulates MET to influence the proliferation and invasion of glioma. Int J Biochem Cell Biol 44(11):1711–1717. doi:10.1016/j.biocel.2012.06.027
20. Gattolliat CH, Thomas L, Ciafre SA, Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P, Valteau-Couanet D, May E, Busson P, Douc-Rasy S, Benard J (2011) Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 105(9):1352–1361. doi:10.1038/bjc.2011.388
21. Carbajo-Pescador S, Ordonez R, Benet M, Jover R, Garcia-Palomo A, Mauriz JL, Gonzalez-Gallego J (2013) Inhibition of VEGF expression through blockade of Hif1alpha and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer 109(1):83–91. doi:10.1038/bjc.2013.285
22. Ugarte-Berzal E, Redondo-Munoz J, Eroles P, Del Cerro MH, Garcia-Marco JA, Terol MJ, Garcia-Pardo A (2010) VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration. Blood 115(4):846–849. doi:10.1182/blood-2009-08-239426
23. Findley CM, Cudmore MJ, Ahmed A, Kontos CD (2007) VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 27(12):2619–2626. doi:10.1161/ATVBAHA.107.150482
24. Lee KS, Park SJ, Kim SR, Min KH, Lee KY, Choe YH, Hong SH, Lee YR, Kim JS, Hong SJ, Lee YC (2008) Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway. Eur Respir J 31(3):523–531. doi:10.1183/09031936.00125007